banner add

Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.

from NYT > Health https://ift.tt/pUmI5sh
via IFTTT

No comments

Evidence Against Drinking Has Grown. Will Federal Advice Change?

Officials in other countries are warning about the health hazards of alcohol in any amount. Americans are still told that moderate drinking ...

Theme images by PLAINVIEW. Powered by Blogger.